Comprehensive analysis of EML2 as a prognostic biomarker in colon cancer

CONCLUSION: The findings revealed that colon cancer tissues had a higher EML2 expression than normal colon epithelial tissues. This phenomenon was significantly associated with poor prognosis and altered immune cell infiltration. Consequently, EML2 has shown the capacity to serve as a prognostic biomarker for patients diagnosed with colon cancer.PMID:38322176 | PMC:PMC10839246
Source: International Journal of Clinical and Experimental Pathology - Category: Pathology Authors: Source Type: research